Category: Diseases & Conditions
Diseases & Conditions market research reports by Nova One Advisor
-
U.S. Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices), By Therapy Area (Stroke, Parkinson’s Disease),- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033
U.S. Neurorehabilitation Devices Market Size and Research The U.S. neurorehabilitation devices market size was exhibited at USD 699.51 million in 2023 and is projected to hit around USD 2,416.90 million by 2033, growing at a CAGR of 13.2% during the forecast period 2024 to 2033. U.S. Neurorehabilita ... Read More
-
U.S. Compounding Pharmacies Market (By Pharmacy Type: 503A, 503B; By Product: Oral, Liquid Preparations, Topical, Rectal, Ophthalmic, Nasal, Otic; By Sterility: Sterile, Non-Sterile; By Compounding Type: PIA, CUPM, PDA, Others; By Therapeutic Area: Hormone replacement, Pain management, Dermatology, Pediatrics, Urology, Others; By End-User: Hospitals and Clinics, Specialty Clinics, Others) - Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
U.S. Compounding Pharmacies Market Size and Forecast 2024 to 2033 The U.S. compounding pharmacies market size is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033. U.S. Compounding Pharmacies Market Key Takeaways By Product, the ... Read More
-
Clinical Nutrition For Diabetes Care Market Size, Share & Trends Analysis Report By Product (Oral, Enteral Feeding Formulas, Parenteral Nutrition), By Stage, By Sales Channel, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global clinical nutrition for diabetes care market size was estimated at USD 2.31 billion in 2023 and is projected to hit around USD 3.69 billion by 2033, growing at a CAGR of 4.79% during the forecast period from 2024 to 2033. Key Takeaways: North America clinical nutrition for diabetes care ma ... Read More
-
U.S. Oncology Molecular Diagnostics Market (By Type: Breast Cancer, Liver Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer, By Technology; PCR, Sequencing, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, TMA, Others; By Product, Reagents, Instruments, Others)) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
The U.S. oncology molecular diagnostics market size was estimated at USD 0.85 billion in 2023 and is projected to hit around USD 2.74 billion by 2033, growing at a CAGR of 12.41% during the forecast period from 2024 to 2033. U.S. Oncology Molecular Diagnostics Market Key Takeaways By type, the breas ... Read More
-
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report By Type (SPECT, PET), By PET Product (F-18, SR-82/RB-82), And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
The U.S. prostate cancer nuclear medicine diagnostics market size reached USD 119.06 million in 2023 and is projected to hit around USD 289.71 million by 2033, expanding at a CAGR of 9.2% during the forecast period from 2024 to 2033. Key Takeaways: The SPECT segment held the largest market share of ... Read More
Research Assistance
